Renal & Nephrology Drugs
91 drugs
- AllopurinolXanthine Oxidase Inhibitor
- Amlodipine 5–10mgCalcium Channel Blocker (Dihydropyridine)
- Atorvastatin (CKD Cardiovascular Risk)Cardiovascular Risk in CKD
- AtrasentanSelective Endothelin-A Receptor Antagonist (Diabetic Nephropathy)
- AvacopanANCA Vasculitis
- AvacopanC5a Receptor Inhibitor (ANCA Vasculitis)
- Azathioprine 1–3mg/kg/dayThiopurine Immunosuppressant
- BasiliximabAnti-IL-2 receptor monoclonal antibody (induction immunosuppression)
- BelataceptT-cell co-stimulation blocker (CTLA-4 fusion)
- Belimumab (Lupus Nephritis)Lupus Nephritis
- Bisoprolol (Cardiorenal Syndrome / CKD)Cardiorenal Syndrome / Hypertension in CKD
- BumetanideLoop Diuretic
- BurosumabAnti-FGF23 Monoclonal Antibody (X-Linked Hypophosphataemia)
- CalcitriolVitamin D Analogue
- CalcitriolActive Vitamin D Analogue (CKD-MBD / Secondary Hyperparathyroidism)
- Calcium acetatePhosphate binder (calcium-based)
- Calcium Acetate 667mg (PhosEx)Phosphate Binder (Calcium-Based)
- Calcium acetate with magnesium carbonateCombination phosphate binder
- Calcium polystyrene sulfonateCation-exchange resin
- Canagliflozin (CKD)CKD Nephroprotection
- CiclosporinCalcineurin Inhibitor (CNI)
- CinacalcetCalcimimetic
- Citric acid with potassium citrateUrinary alkalinisation
- Colecalciferol 1000–2000 units/dayVitamin D Supplement (Native Vitamin D3)
- Cyclophosphamide (Nephrology)ANCA Vasculitis / Lupus Nephritis
- DapagliflozinSGLT2 Inhibitor
- Dapagliflozin (CKD Indication)SGLT2 Inhibitor (CKD — Renoprotective)
- Darbepoetin AlfaErythropoiesis-Stimulating Agent (Long-Acting ESA)
- Deferoxamine (Iron/Aluminium Overload in Dialysis)Iron/Aluminium Overload in Dialysis
- DifelikefalinPeripherally restricted kappa-opioid agonist
- Doxazosin (Hypertension/BPH in CKD)Hypertension in CKD
- EculizumabAtypical HUS / Complement-Mediated Disease
- Empagliflozin (CKD Indication)SGLT2 Inhibitor (CKD — Renoprotective)
- Empagliflozin (CKD)CKD Nephroprotection
- Epoetin AlfaErythropoiesis-Stimulating Agent
- Epoetin betaErythropoiesis-stimulating agent
- Epoetin zetaErythropoiesis-stimulating agent (biosimilar)
- EtelcalcetideCalcimimetic (IV)
- Febuxostat (CKD)Gout in CKD
- Ferric CarboxymaltoseIntravenous Iron
- FinerenoneCKD Nephroprotection
- FinerenoneNon-Steroidal Mineralocorticoid Receptor Antagonist (Diabetic CKD)
- FludrocortisoneMineralocorticoid
- Furosemide 40–500mg oral / 20–200mg IVLoop Diuretic
- Gabapentin (CKD Dosing)Uraemic Pruritus / Neuropathic Pain in CKD
- Gentamicin (Renal Dosing/TDM)Antibiotic Dosing in CKD
- Iron Sucrose (Venofer) 100–200mg IVIntravenous Iron
- Ketoanalogues of Essential Amino AcidsCKD — Nutritional Supplement (Very Low Protein Diet)
- Lanthanum carbonatePhosphate binder
- Lanthanum CarbonatePhosphate Binder (Non-Calcium-Based)
- Lanthanum Carbonate 750mg–3g/day (Fosrenol)Phosphate Binder (Lanthanum-Based)
- LumasiransiRNA targeting glycolate oxidase (HAO1)
- Mannitol (Osmotic Diuretic — Renal/Neurological)Acute Oliguric Renal Failure / Raised ICP
- Mercaptamine (cysteamine)Aminothiol — cystine-depleting
- Methoxy polyethylene glycol-epoetin betaLong-acting erythropoiesis-stimulating agent
- Methylprednisolone IV Pulse (Nephrology)Glomerulonephritis / Vasculitis
- MetolazoneThiazide-Like Diuretic
- Midodrine (Intradialytic Hypotension)Haemodialysis
- Mycophenolate MofetilAntiproliferative Immunosuppressant
- N-Acetylcysteine (Contrast Nephropathy)Contrast-Induced Nephropathy Prevention
- Nitrofurantoin (CKD Contraindication)Antibiotic Dosing in CKD
- ParicalcitolVitamin D analogue
- PatiromerPotassium Binder
- Patiromer calciumPotassium binder
- PhosphatePhosphate replacement
- Potassium aminobenzoatePotassium para-aminobenzoate
- Potassium chloridePotassium replacement
- Potassium chloride with potassium bicarbonateEffervescent potassium replacement
- Potassium citrate with potassium bicarbonateUrinary alkaliniser
- Prednisolone 1mg/kg/day (max 60–80mg)Corticosteroid (Oral)
- Ramipril 2.5–10mgACE Inhibitor
- RasburicaseTumour Lysis Syndrome
- Rituximab (Nephrology)ANCA Vasculitis / Nephrotic Syndrome
- RoxadustatHIF-PHI — Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (Anaemia of CKD)
- SevelamerPhosphate Binder
- Sodium BicarbonateAlkalinising Agent
- Sodium BicarbonateAlkali Therapy (Metabolic Acidosis / CKD-Related Acidosis)
- Sodium Bicarbonate (CKD Acidosis)Alkalinising Agent
- Sodium Polystyrene SulfonateHyperkalaemia
- Sodium Zirconium CyclosilicatePotassium Binder
- SparsentanDual Endothelin/Angiotensin Receptor Antagonist (IgA Nephropathy)
- Spironolactone (Resistant Hypertension in CKD)Hypertension in CKD
- Sucroferric oxyhydroxideIron-based phosphate binder
- TacrolimusCalcineurin Inhibitor (CNI)
- TenapanorNHE3 Inhibitor — Intestinal Phosphate Absorption Reducer
- Tolvaptan (ADPKD)ADPKD
- Trimethoprim (CKD Considerations)Antibiotic Dosing in CKD
- VadadustatHIF prolyl hydroxylase inhibitor
- Vancomycin (Renal Dosing)Antibiotic Dosing in CKD
- VoclosporinLupus Nephritis
- VoclosporinCalcineurin inhibitor